FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155722011> ?p ?o ?g. }

• W2155722011 endingPage "5087" @default.
• W2155722011 startingPage "5074" @default.
• W2155722011 abstract "Considerable uncertainty exists regarding relative effects of allogeneic peripheral blood stem cells transplantation (PBSCT) versus bone marrow transplantation (BMT) on outcomes of patients with hematologic malignancies.To provide the totality of research evidence related to the effects of PBSCT versus BMT, we conducted an individual-patient data meta-analysis using data from nine randomized trials enrolling 1,111 adult patients.Compared with BMT, PBSCT led to faster neutrophil (odds ratio [OR] = 0.31; 95% CI, 0.25 to 0.38; P < .00001) and platelet engraftment (OR = 0.52; 95% CI, 0.44 to 0.61; P < .00001). PBSCT was associated with a significant increase in the development of grade 3-4 acute graft-versus-host disease (GVHD; OR = 1.39; 95% CI, 1.03 to 1.88) and extensive (47% v 31% at 3 years; OR = 1.89; 95% CI, 1.47 to 2.42; P < .000001) and overall chronic GVHD (68% v 52% at 3 years; OR = 1.92; 95% CI, 1.47 to 2.49; P < .000001), but not grade 2-4 acute GVHD (54% v 53%; P = .49). PBSCT was associated with a decrease in relapse (21% v 27% at 3 years; OR = 0.71; 95% CI, 0.54 to 0.93; P = .01) in both late-stage-(33% v 51% at 3 years; OR = 0.59; 95% CI, 0.38 to 0.93; P = .02) and early-stage-disease patients (16% v 20% at 3 years; OR = 0.69; 95% CI, 0.49 to 0.98; P = .04). Nonrelapse mortality was not different between groups. Overall and disease-free survival were only statistically significantly improved in patients with late-stage disease (overall survival: 46% v 31% at 3 years; OR = 0.64; 95% CI, 0.46 to 0.90; P = .01; disease-free survival: 41% v 27% at 3 years; OR = 0.63 95% CI, 0.45 to 0.87; P = .01).PBSCT is associated with a decreased relapse rate in hematologic malignancies and improvement in overall and disease-free survival in patients with late-stage disease. PBSCT is also associated with a significant risk of extensive chronic GVHD." @default.
• W2155722011 created "2016-06-24" @default.
• W2155722011 creator A5006476470 @default.
• W2155722011 creator A5007212903 @default.
• W2155722011 creator A5013069241 @default.
• W2155722011 creator A5021167699 @default.
• W2155722011 creator A5022161221 @default.
• W2155722011 creator A5029278364 @default.
• W2155722011 creator A5046387225 @default.
• W2155722011 creator A5049500556 @default.
• W2155722011 creator A5066560929 @default.
• W2155722011 creator A5068789733 @default.
• W2155722011 creator A5071375525 @default.
• W2155722011 creator A5072582820 @default.
• W2155722011 creator A5072642236 @default.
• W2155722011 creator A5074115908 @default.
• W2155722011 creator A5083504452 @default.
• W2155722011 creator A5091222951 @default.
• W2155722011 creator A5091406853 @default.
• W2155722011 date "2005-08-01" @default.
• W2155722011 modified "2023-10-18" @default.
• W2155722011 title "Allogeneic Peripheral Blood Stem-Cell Compared With Bone Marrow Transplantation in the Management of Hematologic Malignancies: An Individual Patient Data Meta-Analysis of Nine Randomized Trials" @default.
• W2155722011 cites W102095272 @default.
• W2155722011 cites W1262485082 @default.
• W2155722011 cites W1934677454 @default.
• W2155722011 cites W1965974612 @default.
• W2155722011 cites W1973617793 @default.
• W2155722011 cites W1983235867 @default.
• W2155722011 cites W1991897282 @default.
• W2155722011 cites W2000442546 @default.
• W2155722011 cites W2004334502 @default.
• W2155722011 cites W2006633630 @default.
• W2155722011 cites W2007255379 @default.
• W2155722011 cites W2011932878 @default.
• W2155722011 cites W2024835620 @default.
• W2155722011 cites W2025459079 @default.
• W2155722011 cites W2030154801 @default.
• W2155722011 cites W2042403645 @default.
• W2155722011 cites W2071336127 @default.
• W2155722011 cites W2071360821 @default.
• W2155722011 cites W2099306009 @default.
• W2155722011 cites W2106228247 @default.
• W2155722011 cites W2119452552 @default.
• W2155722011 cites W2128570566 @default.
• W2155722011 cites W2137876741 @default.
• W2155722011 cites W2139349555 @default.
• W2155722011 cites W2164761946 @default.
• W2155722011 cites W2170173758 @default.
• W2155722011 cites W221385556 @default.
• W2155722011 cites W2240289126 @default.
• W2155722011 cites W2262982217 @default.
• W2155722011 cites W2291159714 @default.
• W2155722011 cites W2314606814 @default.
• W2155722011 cites W2325869703 @default.
• W2155722011 cites W2337680764 @default.
• W2155722011 cites W2597616474 @default.
• W2155722011 cites W4214559180 @default.
• W2155722011 cites W4235854784 @default.
• W2155722011 cites W4242981571 @default.
• W2155722011 cites W4252927229 @default.
• W2155722011 cites W7016223 @default.
• W2155722011 doi "https://doi.org/10.1200/jco.2005.09.020" @default.
• W2155722011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16051954" @default.
• W2155722011 hasPublicationYear "2005" @default.
• W2155722011 type Work @default.
• W2155722011 sameAs 2155722011 @default.
• W2155722011 citedByCount "399" @default.
• W2155722011 countsByYear W21557220112012 @default.
• W2155722011 countsByYear W21557220112013 @default.
• W2155722011 countsByYear W21557220112014 @default.
• W2155722011 countsByYear W21557220112015 @default.
• W2155722011 countsByYear W21557220112016 @default.
• W2155722011 countsByYear W21557220112017 @default.
• W2155722011 countsByYear W21557220112018 @default.
• W2155722011 countsByYear W21557220112019 @default.
• W2155722011 countsByYear W21557220112020 @default.
• W2155722011 countsByYear W21557220112021 @default.
• W2155722011 countsByYear W21557220112022 @default.
• W2155722011 countsByYear W21557220112023 @default.
• W2155722011 crossrefType "journal-article" @default.
• W2155722011 hasAuthorship W2155722011A5006476470 @default.
• W2155722011 hasAuthorship W2155722011A5007212903 @default.
• W2155722011 hasAuthorship W2155722011A5013069241 @default.
• W2155722011 hasAuthorship W2155722011A5021167699 @default.
• W2155722011 hasAuthorship W2155722011A5022161221 @default.
• W2155722011 hasAuthorship W2155722011A5029278364 @default.
• W2155722011 hasAuthorship W2155722011A5046387225 @default.
• W2155722011 hasAuthorship W2155722011A5049500556 @default.
• W2155722011 hasAuthorship W2155722011A5066560929 @default.
• W2155722011 hasAuthorship W2155722011A5068789733 @default.
• W2155722011 hasAuthorship W2155722011A5071375525 @default.
• W2155722011 hasAuthorship W2155722011A5072582820 @default.
• W2155722011 hasAuthorship W2155722011A5072642236 @default.
• W2155722011 hasAuthorship W2155722011A5074115908 @default.
• W2155722011 hasAuthorship W2155722011A5083504452 @default.
• W2155722011 hasAuthorship W2155722011A5091222951 @default.
• W2155722011 hasAuthorship W2155722011A5091406853 @default.
• W2155722011 hasBestOaLocation W21557220111 @default.

• next